Fathman; C. Garrison

Patent Applications and Registrations

Patent applications and USPTO patent grants for Fathman; C. Garrison.The latest application filed is for "combination of low dose il-2 and an inhibitor of treg il-2r desensitization to treat autoimmune and allergic inflammatory diseases".

Company Profile

1.13.10

Fathman; C. Garrison - Stanford CA
Fathman; C. Garrison - Portonal Valley CA
Fathman; C. Garrison - Portola Valley CA
Fathman; C. Garrison - Fortola Valley CA
Fathman; C. Garrison - Menlo Park CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Of Low Dose Il-2 And An Inhibitor Of Treg Il-2r Desensitization To Treat Autoimmune And Allergic Inflammatory Diseases App 20210379155 - Fathman; C. Garrison ; et al.	2021-12-09
Biologically Modified Vascular Grafts For Improved Bypass Surgery Outcomes App 20200246127 - Kind Code	2020-08-06
Compositions and methods for treating diseases Grant 9,220,744 - Rothbard , et al. December 29, 2	2015-12-29
Compositions and methods for treating diseases App 20140342986 - Rothbard; Jonathan B. ; et al.	2014-11-20
Compositions and methods for treating diseases Grant 8,629,115 - Rothbard , et al. January 14, 2	2014-01-14
Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection Grant 8,513,208 - Nicolette , et al. August 20, 2	2013-08-20
Polypeptide complex that regulates cell cycle and anergy Grant 7,964,369 - Fathman , et al. June 21, 2	2011-06-21
Compositions and methods for treating diseases App 20110124584 - Rothbard; Jonathan B. ; et al.	2011-05-26
Transient Expression Of Immunomodulatory Polypeptides For The Prevention And Treatment Of Autoimmune Disease, Allergy And Transplant Rejection App 20110081327 - Nicolette; Charles A. ; et al.	2011-04-07
Compositions and methods for treating diseases Grant 7,820,626 - Rothbard , et al. October 26, 2	2010-10-26
Compositions and methods for treating diseases Grant 7,557,087 - Rothbard , et al. July 7, 2	2009-07-07
Compositions And Methods For Treating Diseases App 20090053283 - Rothbard; Jonathan B. ; et al.	2009-02-26
Polypeptide Complex that Regulates Cell Cycle and Anergy App 20090012017 - Fathman; C. Garrison ; et al.	2009-01-08
Gene therapy for the prevention of autoimmune disease Grant 7,378,089 - Fathman May 27, 2	2008-05-27
Compositions and Methods for Treating Diseases App 20070185203 - Rothbard; Jonathan B. ; et al.	2007-08-09
Compositions and methods for treating diseases App 20050192210 - Rothbard, Jonathan B. ; et al.	2005-09-01
Anergy associated genes Grant 6,709,840 - Ford , et al. March 23, 2	2004-03-23
Gene therapy for the prevention of autoimmune disease App 20030091548 - Fathman, C. Garrison	2003-05-15
Anergy genes Grant 5,747,299 - Bloom , et al. May 5, 1	1998-05-05
Method of conferring immuno-tolerance to a specific antigen Grant 4,904,481 - Fathman * February 27, 1	1990-02-27
Method of conferring immunotolerance to a specific antigen Grant 4,681,760 - Fathman July 21, 1	1987-07-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.